Intralipid for Recurrent Miscarriage

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Abortion, SpontaneousAbortion, Habitual
Interventions
DRUG

Intralipid

IV infusion of intralipid 20% is administrated on the day of vaginal egg collection in a dose of 9 mg/ml total blood volume corresponding to intralipid 2 ml 20% diluted in 250 ml saline over 30-60 minutes.the intralipid infusion is then repeated within the 1st week of positive pregnancy test and every 2 weeks till end of first trimester

Trial Locations (1)

12211

Kasr el ainy hospital, Cairo

All Listed Sponsors
lead

Woman's Health University Hospital, Egypt

OTHER

NCT01788540 - Intralipid for Recurrent Miscarriage | Biotech Hunter | Biotech Hunter